{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:28:29Z","timestamp":1789475309588,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou Municipal Government-University-Institute(-Industry) Joint Funding Program","award":["No. 2025A03J3406"],"award-info":[{"award-number":["No. 2025A03J3406"]}]},{"name":"Guangzhou Municipal Government-University-Institute(-Industry) Joint Funding Program","award":["No. 2025A03J3406"],"award-info":[{"award-number":["No. 2025A03J3406"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05677-0","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:24:20Z","timestamp":1772846660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical efficacy and safety of recombinant human brain natriuretic peptide in the treatment of sepsis complicated by heart failure: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixiang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"8","key":"5677_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"issue":"20","key":"5677_CR2","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1161\/circulationaha.117.032821","volume":"138","author":"Y Sun","year":"2018","unstructured":"Sun Y, Yao X, Zhang QJ, Zhu M, Liu ZP, Ci B, et al. Beclin-1-Dependent Autophagy Protects the Heart During Sepsis. Circulation. 2018;138(20):2247\u201362. https:\/\/doi.org\/10.1161\/circulationaha.117.032821.","journal-title":"Circulation"},{"issue":"4","key":"5677_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/ccm.0000000000002851","volume":"46","author":"SJ Beesley","year":"2018","unstructured":"Beesley SJ, Weber G, Sarge T, Nikravan S, Grissom CK, Lanspa MJ, et al. Septic Cardiomyopathy. Crit Care Med. 2018;46(4):625\u201334. https:\/\/doi.org\/10.1097\/ccm.0000000000002851.","journal-title":"Crit Care Med"},{"issue":"6","key":"5677_CR4","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1097\/CCM.0b013e318174db05","volume":"36","author":"A Vieillard-Baron","year":"2008","unstructured":"Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med. 2008;36(6):1701\u20136. https:\/\/doi.org\/10.1097\/CCM.0b013e318174db05.","journal-title":"Crit Care Med"},{"issue":"12","key":"5677_CR5","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00134-016-4503-4","volume":"42","author":"A Aneman","year":"2016","unstructured":"Aneman A, Vieillard-Baron A. Cardiac dysfunction in sepsis. Intensive Care Med. 2016;42(12):2073\u20136. https:\/\/doi.org\/10.1007\/s00134-016-4503-4.","journal-title":"Intensive Care Med"},{"issue":"4","key":"5677_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/shk.0000000000001718","volume":"56","author":"X Tang","year":"2021","unstructured":"Tang X, Xu Y, Dai X, Xing Y, Yang D, Huang Q, et al. The Long-term Effect of Dobutamine on Intrinsic Myocardial Function and Myocardial Injury in Septic Rats with Myocardial Dysfunction. Shock. 2021;56(4):582\u201392. https:\/\/doi.org\/10.1097\/shk.0000000000001718.","journal-title":"Shock"},{"issue":"17","key":"5677_CR7","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","volume":"375","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RM, Santhakumaran S, et al. Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis. N Engl J Med. 2016;375(17):1638\u201348. https:\/\/doi.org\/10.1056\/NEJMoa1609409.","journal-title":"N Engl J Med"},{"issue":"2","key":"5677_CR8","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/ehf2.15082","volume":"12","author":"G Di Pietro","year":"2025","unstructured":"Di Pietro G, Improta R, Severino P, D\u2019Amato A, Birtolo LI, De Filippo O, et al. The in-hospital administration of sacubitril\/valsartan in acute myocardial infarction: A meta-analysis. ESC Heart Fail. 2025;12(2):998\u20131012. https:\/\/doi.org\/10.1002\/ehf2.15082.","journal-title":"ESC Heart Fail"},{"issue":"6","key":"5677_CR9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","volume":"18","author":"SM Hollenberg","year":"2021","unstructured":"Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat reviews Cardiol. 2021;18(6):424\u201334. https:\/\/doi.org\/10.1038\/s41569-020-00492-2.","journal-title":"Nat reviews Cardiol"},{"issue":"4","key":"5677_CR10","doi-asserted-by":"publisher","first-page":"R248","DOI":"10.1186\/cc2889","volume":"8","author":"G Chua","year":"2004","unstructured":"Chua G, Kang-Hoe L. Marked elevations in N-terminal brain natriuretic peptide levels in septic shock. Crit Care. 2004;8(4):R248\u201350. https:\/\/doi.org\/10.1186\/cc2889.","journal-title":"Crit Care"},{"key":"5677_CR11","doi-asserted-by":"publisher","unstructured":"Potz BA, Sellke FW, Abid MR. Endothelial ROS and Impaired Myocardial Oxygen Consumption in Sepsis-induced Cardiac Dysfunction. J intensive Crit care. 2016;2(1). https:\/\/doi.org\/10.21767\/2471-8505.100020.","DOI":"10.21767\/2471-8505.100020"},{"key":"5677_CR12","doi-asserted-by":"publisher","unstructured":"Roch A, Allardet-Servent J, Michelet P, Oddoze C, Forel JM, Barrau K, et al. NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med. 2005;33(5):1001\u20137. https:\/\/doi.org\/10.1097\/01.ccm.000016256. 82012. e9","DOI":"10.1097\/01.ccm"},{"issue":"1","key":"5677_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jamcollsurg.2011.03.027","volume":"213","author":"KL Turner","year":"2011","unstructured":"Turner KL, Moore LJ, Todd SR, Sucher JF, Jones SA, McKinley BA, et al. Identification of cardiac dysfunction in sepsis with B-type natriuretic peptide. J Am Coll Surg. 2011;213(1):139\u201346. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2011.03.027. discussion 46\u2009\u2013\u20097.","journal-title":"J Am Coll Surg"},{"issue":"7","key":"5677_CR14","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.ejheart.2005.03.003","volume":"7","author":"M Maeder","year":"2005","unstructured":"Maeder M, Ammann P, Kiowski W, Rickli H. B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction. Eur J Heart Fail. 2005;7(7):1164\u20137. https:\/\/doi.org\/10.1016\/j.ejheart.2005.03.003.","journal-title":"Eur J Heart Fail"},{"key":"5677_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40779-016-0099-9","volume":"3","author":"X Lv","year":"2016","unstructured":"Lv X, Wang H. Pathophysiology of sepsis-induced myocardial dysfunction. Military Med Res. 2016;3:30. https:\/\/doi.org\/10.1186\/s40779-016-0099-9.","journal-title":"Military Med Res"},{"key":"5677_CR16","doi-asserted-by":"publisher","first-page":"107863","DOI":"10.1016\/j.pharmthera.2021.107863","volume":"227","author":"K Kuwahara","year":"2021","unstructured":"Kuwahara K. The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications. Pharmacol Ther. 2021;227:107863. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107863.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"5677_CR17","first-page":"537","volume":"16","author":"ZY Xia","year":"2017","unstructured":"Xia ZY, Chai XP. Study on the protective effects of recombinant human brain natriuretic peptide against cardiac injury in septic mice. J Clin Experimental Med. 2017;16(6):537\u201340.","journal-title":"J Clin Experimental Med"},{"issue":"2","key":"5677_CR18","first-page":"138","volume":"24","author":"Y Wang","year":"2018","unstructured":"Wang Y, Shi H, He H, Wang Q, Chen X, Chen Y, et al. Impact of recombinant human brain natriuretic peptide on cardiac function and tissue perfusion in septic shock patients. J Intern Intensive Med. 2018;24(2):138\u20139.","journal-title":"J Intern Intensive Med"},{"issue":"6","key":"5677_CR19","doi-asserted-by":"publisher","first-page":"478","DOI":"10.13201\/j.issn.1009-5918.2020.06.012","volume":"21","author":"G Liu","year":"2020","unstructured":"Liu G, Chen W, Hu H, Chen P, Wu X, He Y. Therapeutic effect of recombinant human brain natriuretic peptide on patients with sepsis and cardiorenal syndrome. J Clin Emerg. 2020;21(6):478\u201381. https:\/\/doi.org\/10.13201\/j.issn.1009-5918.2020.06.012.","journal-title":"J Clin Emerg"},{"issue":"5","key":"5677_CR20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s41999-019-00229-6","volume":"10","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhang Y, Li X. Roles of small-dose recombinant human brain natriuretic peptide without bolus in Chinese older patients with septic cardiac dysfunction. Eur Geriatr Med. 2019;10(5):721\u20136. https:\/\/doi.org\/10.1007\/s41999-019-00229-6.","journal-title":"Eur Geriatr Med"},{"issue":"1","key":"5677_CR21","first-page":"100","volume":"43","author":"X Hua","year":"2022","unstructured":"Hua X, Cao L, Wang Y. Efficacy and safety of rh-BNP combined with levosimendan in treatment of elderly patients with sepsis-induced myocardial dysfunction. J Tongji Univ (Medical Science). 2022;43(1):100\u20136. \/ j. issn. 1008\u2009\u2013\u20090392. 21332.","journal-title":"J Tongji Univ (Medical Science)"},{"key":"5677_CR22","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"5677_CR23","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","DOI":"10.1136\/bmj.l4898"},{"issue":"5","key":"5677_CR24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.bja.2019.08.015","volume":"123","author":"A Granholm","year":"2019","unstructured":"Granholm A, Alhazzani W, M\u00f8ller MH. Use of the GRADE approach in systematic reviews and guidelines. Br J Anaesth. 2019;123(5):554\u20139. https:\/\/doi.org\/10.1016\/j.bja.2019.08.015.","journal-title":"Br J Anaesth"},{"issue":"1","key":"5677_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2307\/2530643","volume":"41","author":"S Greenland","year":"1985","unstructured":"Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics. 1985;41(1):55\u201368.","journal-title":"Biometrics"},{"issue":"2","key":"5677_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2307\/2531052","volume":"42","author":"J Robins","year":"1986","unstructured":"Robins J, Breslow N, Greenland S. Estimators of the Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models. Biometrics. 1986;42(2):311\u201323.","journal-title":"Biometrics"},{"issue":"Pt A","key":"5677_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","volume":"45","author":"R DerSimonian","year":"2015","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45(Pt A):139\u201345. https:\/\/doi.org\/10.1016\/j.cct.2015.09.002.","journal-title":"Contemp Clin Trials"},{"issue":"12","key":"5677_CR28","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence\u2013inconsistency. J Clin Epidemiol. 2011;64(12):1294\u2013302. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.03.017.","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"5677_CR29","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1161\/cir.0000000000000523","volume":"136","author":"G Rao","year":"2017","unstructured":"Rao G, Lopez-Jimenez F, Boyd J, D\u2019Amico F, Durant NH, Hlatky MA, et al. Methodological Standards for Meta-Analyses and Qualitative Systematic Reviews of Cardiac Prevention and Treatment Studies: A Scientific Statement From the American Heart Association. Circulation. 2017;136(10):e172\u201394. https:\/\/doi.org\/10.1161\/cir.0000000000000523.","journal-title":"Circulation"},{"issue":"7","key":"5677_CR30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/biology10070601","volume":"10","author":"D Guti\u00e9rrez Mu\u00f1oz","year":"2021","unstructured":"Guti\u00e9rrez Mu\u00f1oz D, Obrador Aldover C, Zubizarreta-Macho \u00c1, Gonz\u00e1lez Men\u00e9ndez H, Lorrio Castro J, Pe\u00f1arrocha-Oltra D, et al. Survival Rate and Prosthetic and Sinus Complications of Zygomatic Dental Implants for the Rehabilitation of the Atrophic Edentulous Maxilla: A Systematic Review and Meta-Analysis. Biology (Basel). 2021;10(7):601. https:\/\/doi.org\/10.3390\/biology10070601.","journal-title":"Biology (Basel)"},{"issue":"11","key":"5677_CR31","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358. https:\/\/doi.org\/10.1002\/sim.1186.","journal-title":"Stat Med"},{"issue":"4","key":"5677_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ajodo.2020.07.002","volume":"158","author":"LM Spineli","year":"2020","unstructured":"Spineli LM, Pandis N. Exploring heterogeneity in meta-analysis: Meta-regression analysis. Am J Orthod Dentofac Orthop. 2020;158(4):623\u20135. https:\/\/doi.org\/10.1016\/j.ajodo.2020.07.002.","journal-title":"Am J Orthod Dentofac Orthop"},{"issue":"10","key":"5677_CR33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S2213-2600(23)00137-6","volume":"11","author":"CJW Low","year":"2023","unstructured":"Low CJW, Ramanathan K, Ling RR, Ho MJC, Chen Y, Lorusso R, et al. Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with cardiac arrest: a comparative meta-analysis and trial sequential analysis. Lancet Respir Med. 2023;11(10):883\u201393. https:\/\/doi.org\/10.1016\/S2213-2600(23)00137-6.","journal-title":"Lancet Respir Med"},{"issue":"25","key":"5677_CR34","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1002\/sim.2889","volume":"26","author":"JL Peters","year":"2007","unstructured":"Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med. 2007;26(25):4544\u201362. https:\/\/doi.org\/10.1002\/sim.2889.","journal-title":"Stat Med"},{"issue":"1","key":"5677_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jtcvs.2020.06.063","volume":"162","author":"JSK Chan","year":"2021","unstructured":"Chan JSK, Harky A. Trial sequential analysis in meta-analyses: A clinically oriented approach with real-world example. J Thorac Cardiovasc Surg. 2021;162(1):167\u201373. https:\/\/doi.org\/10.1016\/j.jtcvs.2020.06.063.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"14","key":"5677_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.7619\/jcmp.202014033","volume":"24","author":"H Song","year":"2020","unstructured":"Song H, Pan LP, Shao ZH. Monitoring of pulse indicator continuous cardiac output in patients with severe sepsis complicated with heart failure treated by recombinant human brain natriuretic peptide. J Clin Med Pract. 2020;24(14):119\u201321. https:\/\/doi.org\/10.7619\/jcmp.202014033.","journal-title":"J Clin Med Pract"},{"issue":"8","key":"5677_CR37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3969\/j.issn.1002-1949.2016.08.001","volume":"36","author":"HY Yin","year":"2016","unstructured":"Yin HY, Qiu M, Ma Y, Ye XL. Curative effect of recombinant human brain natriuretic peptide for septic patients with cardiac insufficiency. Chin J Crit Care Med. 2016;36(8):673\u20138. https:\/\/doi.org\/10.3969\/j.issn.1002-1949.2016.08.001.","journal-title":"Chin J Crit Care Med"},{"key":"5677_CR38","volume-title":"Association between administration of recombinant human brain natriuretic peptide and in-hospital mortality in patients with sepsis-related myocardial injury","author":"QR Wen","year":"2024","unstructured":"Wen QR. Association between administration of recombinant human brain natriuretic peptide and in-hospital mortality in patients with sepsis-related myocardial injury. Guangzhou, China: Guangzhou Medical University; 2024."},{"key":"5677_CR39","volume-title":"Effect of recombinant human brain natriuretic peptide on renalfunction in patients with septic cardiac insufficiency: a clinical cohort study","author":"N Wei","year":"2021","unstructured":"Wei N. Effect of recombinant human brain natriuretic peptide on renalfunction in patients with septic cardiac insufficiency: a clinical cohort study. Guangdong, China: Guangdong Medical University; 2021."},{"issue":"6","key":"5677_CR40","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.7501\/j.issn.1674-5515.2025.06.014","volume":"40","author":"MS Xu","year":"2025","unstructured":"Xu MS, Bao z, Duan MM, Yang MH, Dong Y, Ma YL, et al. Clinical study on Xuebijing Injection combined with recombinant human brain natriuretic peptide in treatment of septic cardiomyopathy. Drugs Clin. 2025;40(6):1439\u201344. https:\/\/doi.org\/10.7501\/j.issn.1674-5515.2025.06.014.","journal-title":"Drugs Clin"},{"issue":"1","key":"5677_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3969\/j.issn.1672-9463.2024.01.011","volume":"26","author":"L Jia","year":"2024","unstructured":"Jia L. Effect of Levosimendan Combined with Recombinant Human Brain Natriuretic Peptide (rhBNP) on Serum Sepsis Markers and Hemodynamic Parameters in Patients with Septic Cardiomyopathy. Mod Med J China. 2024;26(1):51\u20134. https:\/\/doi.org\/10.3969\/j.issn.1672-9463.2024.01.011.","journal-title":"Mod Med J China"},{"issue":"5","key":"5677_CR42","first-page":"40","volume":"21","author":"CY Wu","year":"2022","unstructured":"Wu CY, Su RW, Liu B, Ye XQ, Zhong SB. Observation of the curative effect of Shenfu injection combined with rhBNP on septic heart failure. J Anhui Med Coll. 2022;21(5):40\u20132.","journal-title":"J Anhui Med Coll"},{"issue":"22","key":"5677_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3969\/j.issn.1005-8257.2022.22.015","volume":"29","author":"YP Zhai","year":"2022","unstructured":"Zhai YP, Pan JY, Wang ZM, He YJ, Zhang CY, Liao Q, et al. Clinical effect of CRRT combined with neovitin on ICU sepsis complicated with heart failure. Capital Food Med. 2022;29(22):28\u201330. https:\/\/doi.org\/10.3969\/j.issn.1005-8257.2022.22.015.","journal-title":"Capital Food Med"},{"issue":"10","key":"5677_CR44","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3969\/j.issn.1672-3511.2021.10.025","volume":"33","author":"JN Wu","year":"2021","unstructured":"Wu JN, Cheng Q, Gao G, Fu H, Jin L. Efficacy of CRRT combined with lyophilized recombinant human brain natriuretic peptide on sepsis with heart failure and its effects on serum PCT, IL-6, CRP and cardiac function indexes. Med J West China. 2021;33(10):1526\u201330. https:\/\/doi.org\/10.3969\/j.issn.1672-3511.2021.10.025.","journal-title":"Med J West China"},{"key":"5677_CR45","unstructured":"Nct. Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure. https:\/\/clinicaltrials.gov\/study\/NCT05111769. 2021."},{"key":"5677_CR46","first-page":"107","volume":"11","author":"Q Zhang","year":"2023","unstructured":"Zhang Q. Effect Analysis of CRRT combined with Xinhuosu in treating ICU patients with sepsis and heart failure. Med HYGIENE. 2023;11:107\u20139.","journal-title":"Med HYGIENE"},{"issue":"4","key":"5677_CR47","first-page":"14","volume":"23","author":"B Peipei Teng","year":"2023","unstructured":"Peipei Teng B, Zheng. Clinical observation of continuous renal replacement rherapy combined with lyophilized rhBNP in treating sepsis with heart failure. Practical Clin J Integr Traditional Chin Western Med. 2023;23(4):14\u20136.","journal-title":"Practical Clin J Integr Traditional Chin Western Med"},{"issue":"16","key":"5677_CR48","first-page":"6","volume":"13","author":"C Liwei Lin","year":"2023","unstructured":"Liwei Lin C, Li J, Zhang B, Zhao. Study on the efficacy of rhBNP combined with metoprolol in sepsis and heart failure patients, and its impact on cardiac function indicators. Prev Treat Cardiovasc Disease. 2023;13(16):6\u20138.","journal-title":"Prev Treat Cardiovasc Disease"},{"issue":"3","key":"5677_CR49","doi-asserted-by":"publisher","first-page":"379","DOI":"10.16766\/j.cnki.issn.1674-4152.002357","volume":"20","author":"B Wang","year":"2022","unstructured":"Wang B, Cai X, Lin L. Effect of recombinant human brain natriuretic peptide combined with levosimendan in patients with septic heart failure. Chin J Gen Pract. 2022;20(3):379\u201383. https:\/\/doi.org\/10.16766\/j.cnki.issn.1674-4152.002357.","journal-title":"Chin J Gen Pract"},{"key":"5677_CR50","first-page":"275","volume":"9","author":"J Lin","year":"2023","unstructured":"Lin J, Wang D. Observation on the Efficacy of Recombinant Human Brain Natriuretic Peptide Combined with Levosimendan in the Treatment of Heart Failure Caused by Sepsis. Health Friends. 2023;9:275\u20137.","journal-title":"Health Friends"},{"key":"5677_CR51","unstructured":"Hongjuan Liu. Effect of levosimendan combined with rh-BNP on cardiac function and apoptotic protein in patients with sepsis-induced acute heart failure. Medical Science Journal of Central South China. 2019;47(6):606\u2013609. Chinese. doi: 10. 15972 \/ j. cnki. 43-1509 \/ r. 2019. 06. 011."},{"issue":"1","key":"5677_CR52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3892\/etm.2020.8667","volume":"20","author":"Y Peng","year":"2020","unstructured":"Peng Y, Wei H. Role of recombinant human brain natriuretic peptide combined with sodium nitroprusside in improving quality of life and cardiac function in patients with acute heart failure. Exp Ther Med. 2020;20(1):261\u20138. https:\/\/doi.org\/10.3892\/etm.2020.8667.","journal-title":"Exp Ther Med"},{"issue":"5","key":"5677_CR53","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/MAJ.0000000000000461","volume":"349","author":"Z Jia","year":"2015","unstructured":"Jia Z, Guo M, Zhang LY, Zhang YQ, Liang HQ, Song Y. Levosimendan and nesiritide as a combination therapy in patients with acute heart failure. Am J Med Sci. 2015;349(5):398\u2013405. https:\/\/doi.org\/10.1097\/MAJ.0000000000000461.","journal-title":"Am J Med Sci"},{"issue":"4","key":"5677_CR54","doi-asserted-by":"publisher","first-page":"2201514","DOI":"10.1183\/13993003.01514-2022","volume":"61","author":"F Salton","year":"2023","unstructured":"Salton F, Confalonieri P, Centanni S, Mondoni M, Petrosillo N, Bonfanti P, et al. Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS). Eur Respir J. 2023;61(4):2201514. https:\/\/doi.org\/10.1183\/13993003.01514-2022.","journal-title":"Eur Respir J"},{"key":"5677_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2261-14-31","volume":"14","author":"HY Pan","year":"2014","unstructured":"Pan HY, Zhu JH, Gu Y, Yu XH, Pan M, Niu HY. Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with different blood BNP levels. BMC Cardiovasc Disord. 2014;14:31. https:\/\/doi.org\/10.1186\/1471-2261-14-31.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"5677_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12872-025-04609-8","volume":"25","author":"R Meng","year":"2025","unstructured":"Meng R, Li X, Liu H, Yi Z, Han Y, Xie Q, et al. The comparative study of the efficacy of recombinant human brain natriuretic peptide combined with vasoactive medications for elderly patients with heart failure and hypotension receiving injections. BMC Cardiovasc Disord. 2025;25(1):185. https:\/\/doi.org\/10.1186\/s12872-025-04609-8.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"5677_CR57","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1056\/NEJM200007273430403","volume":"343","author":"WS Colucci","year":"2000","unstructured":"Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Johnson AD, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med. 2000;343(4):246\u201353. https:\/\/doi.org\/10.1056\/NEJM200007273430403.","journal-title":"N Engl J Med"},{"key":"5677_CR58","doi-asserted-by":"publisher","unstructured":"Wang L, Gao Z, Xu Z, Cheng L, Yin S. Effect of recombinant human brain natriuretic peptide on efficacy, hemodynamics and NT-proBNP in elderly patients with heart failure. Am J Transl Res. 2024;16(6):2517\u201324. https:\/\/doi.org\/10.62347\/DXBA1077.","DOI":"10.62347\/DXBA1077"},{"key":"5677_CR59","doi-asserted-by":"publisher","unstructured":"O\u2019Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011;365(1):32\u201343. https:\/\/doi.org\/10.1056\/NEJMoa1100171.","DOI":"10.1056\/NEJMoa1100171"},{"issue":"6","key":"5677_CR60","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","volume":"13","author":"JT Heywood","year":"2007","unstructured":"Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J, et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007;13(6):422\u201330. https:\/\/doi.org\/10.1016\/j.cardfail.2007.03.011.","journal-title":"J Card Fail"},{"key":"5677_CR61","unstructured":"61.\tU.S. Food and Drug Administration. Natrecor (nesiritide) injection: highlights of prescribing information. 2012. Accessed February 12, 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020920s031lbl.pdf."}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05677-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05677-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05677-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:21:26Z","timestamp":1776169286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05677-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5677"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05677-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}